Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Ovarian cancer classification system validated
Fri January 15th - A newly developed method for subtyping ovarian cancer has been validated as accurately predicting disease outcome. More
How euthanasia rates vary across The Netherlands
Fri January 15th - Regions of The Netherlands have recorded a seven-fold unexplained variation in euthanasia rates, according to new analysis published today. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...

Men may quit cancer monitoring programme

Monday April 14th, 2014

Programmes aimed at monitoring men with slow growing prostate cancer may suffer from patient reluctance to co-operate, Swiss researchers have warned.

Many doctors believe that men with slow-growing cancer may benefit from limited treatment as the disease may never pose a serious threat to their lives.

Last week a British study raised doubts about the ability of doctors and pathologists to identify these patients.

Now the latest study, from Baden, Switzerland, reports that about 25% of men dropped out of a monitoring programme for this kind of cancer.

The doctors reported on the fate of some 157 men monitored over a period of 13 years.

During the period some 28% of men were found to need treatment and were "cured".

But some 27% of men failed to show up for appointments and failed to reply to letters.

The findings were reported to the conference of the European Association of Urology in Stockholm, Sweden.

Researcher Dr Lukas Hefermehl said: "We don’t know exactly what the reasons are. It may be that once the patient was told that this cancer is probably not immediately threatening, he might downplay the importance of another test.

"On the other hand some men might have real concerns about the risk of there being a more severe cancer. Or it may be to do with the risk of incontinence or impotence after treatment, the idea of having cancer, a sense that nothing will really happen to them or it may be due to another reason which we just don’t know about."

He added: "The fact is that overall these findings leave us with a practical and ethical dilemma; we often recommend that men go onto an active surveillance programme, but these results indicate that more than a quarter of men will disappear from the system."

Professor Manfred Wirth, of the Technical University of Dresden and treasurer of the association, said the findings were "potentially controversial."

He said: "It is based on clinical practice in the real world. It shows that we may need a clearer understanding of the psychological factors which might get in the way of effective follow up in these points."

Tags: Cancer | Europe | Menís Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)